NEW YORK (GenomeWeb News) – What were the articles that gained the most interest from GenomeWeb readers last week? Here are the top five:
1) 23andMe Gets FDA Clearance to Market Bloom Syndrome Carrier Test Directly to Consumers
2) FDA Outlines Plan for Expected $10M Under President's Precision Medicine Plan
Registering provides access to this and other free content.
Already have an account?Login Now.
While gene therapies may have high price tags, they could be cheaper than the cost of managing disease, according to MIT's Technology Review.
Researchers are looking for markers that indicate which cancer patients may respond to immunotherapies, the Associated Press writes.
In Nature this week: paternal age associated with de novo mutations in children, and more.
Nature News writes that researchers are still wrangling over the role of the p-value.